{"version":"1.0","type":"link","title":"Conversion surgery after pembrolizumab for initially unresectable MSI-H small bowel adenocarcinoma: a case report and brief analysis.","author_name":"Nakashima Y 외","author_url":"https://prs-insight.online/author/Nakashima%20Y","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/169174","thumbnail_width":1200,"thumbnail_height":630}